Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2026-05-12 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “2025年度股东会决议公告” and provides detailed AGM meeting logistics and vote tallies for each resolution of the 2025 Annual General Meeting. It is a formal announcement of shareholder vote results rather than the full AGM materials, financial report, or proxy statement. This corresponds to the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-05-12 Chinese
药石科技2025年度股东会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion letter issued by a law firm on the company’s 2025 Annual General Meeting. It provides detailed voting results for each resolution (number of shares for, against, abstaining, percentages) at the AGM. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-12 Chinese
2025年度募集资金存放、管理与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage, management, and usage of funds raised by the company through a specific stock issuance in 2020. It includes detailed financial figures, regulatory references to Chinese securities laws and Shenzhen Stock Exchange guidelines, and auditor and sponsor opinions on the fund usage. The document is titled as a "专项报告" (special report) on the 2025 fiscal year fundraising funds usage and management. It contains actual financial data, project investment details, changes in project implementation, and compliance statements. This type of document corresponds to a specialized report on capital raised and its usage, which aligns with the category of Capital/Financing Update (CAP). It is not an annual report, audit report, or earnings release, nor is it a simple announcement or certification. Therefore, the correct classification is CAP with high confidence.
2026-04-21 Chinese
关于2026年度开展外汇衍生品交易预计及授权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding its plan to conduct foreign exchange derivative transactions in the upcoming fiscal year 2026. It includes details about the purpose, investment amount, types of derivative products, risk analysis, risk control measures, and the approval process involving the board and audit committee. The document is relatively short (3199 characters) and primarily serves to inform shareholders and the public about the proposed derivative trading activities and the need for shareholder approval. It does not contain actual financial statements, quarterly or annual financial results, or detailed financial data. It is not a report but an announcement of a planned financial activity requiring shareholder authorization. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including derivative trading authorizations and risk management related to financial instruments.
2026-04-21 Chinese
第四届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 13th meeting of the 4th Board of Directors of Nanjing Yaoshi Technology Co., Ltd. It includes approvals of various reports such as the 2025 Annual Report, 2025 Annual Financial Statements, 2025 Audit Report, and other governance and financial matters. The document repeatedly states that the detailed reports are disclosed separately on the official disclosure website (cninfo.com.cn), indicating this document itself is not the full annual report but a board meeting resolution announcement. The document also includes agenda items related to remuneration, internal control reports, and other governance issues, but the primary purpose is to announce board meeting decisions. The document length is 7572 characters, which is substantial but the content is clearly a board meeting resolution announcement rather than the full annual report or audit report. Therefore, the best fitting category is Board/Management Information (MANG), as it announces board meeting resolutions and management decisions. Confidence is high given the detailed meeting minutes and voting results provided.
2026-04-21 Chinese
2026年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "南京药石科技股份有限公司2026年第一季度报告" which translates to "PharmaBlock 2026 First Quarter Report." It contains detailed financial data including consolidated balance sheets, income statements, cash flow statements, and explanations of financial metrics for the first quarter of 2026. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited, which is common for interim or quarterly reports. There is no indication that this is an announcement of a report or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-04-21 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.